NDC 70518-4532-01 - Gabapentin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70518-4532
- Requested NDC
- 70518-4532-01
- Package NDCs from labels
- 70518-4532-1, 70518-4532-0, 70518-4532-01
- Manufacturer
- REMEDYREPACK INC.
- Effective date
- 2026-10-29
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Gabapentin - REMEDYREPACK INC. | REMEDYREPACK INC. | 2026-10-29 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70518-4532-0 | Gabapentin | 100 in 1 BOX | TABLET, FILM COATED | 100 | 1 | |
| 70518-4532-1 | Gabapentin | 1 in 1 POUCH | TABLET, FILM COATED | 1 | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Gabapentin | GABAPENTIN | A-S Medication Solutions | d25daaac-a8ab-4f12-acc2-4ec8fc97a2d4 | 2025-06-24 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | QUALLENT PHARMACEUTICALS HEALTH LLC | 472bb279-bb4e-4246-b2a3-172483ba356b | 2025-06-23 | Warnings, Adverse reactions | 310433 310434 6CW7F3G59X |
| SENSITIVE POCKET SUN | SENSITIVE POCKET SUN | Shantou Oushiya Biotechnology Co., Ltd | 36ac412f-e31f-6906-e063-6394a90a4a3d | 2025-06-14 | Warnings | 7SEV7J4R1U |
| Gabapentin | GABAPENTIN | Strides Pharma Science Limited | bec31452-b52b-4698-ba4c-0b614780ee84 | 2025-06-14 | Warnings, Adverse reactions | 310433 310434 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Preferred Pharmaceuticals, Inc. | 5d3f27bf-3486-40fa-a4d3-5f0b2c6c0151 | 2025-06-11 | Warnings, Adverse reactions | 310434 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Preferred Pharmaceuticals, Inc. | 561f53d5-5301-42b3-b372-f3d49d642a2e | 2025-06-11 | Warnings, Adverse reactions | 310434 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Direct_Rx | ed9c501c-24e4-da89-e053-2a95a90a64c6 | 2025-06-09 | Warnings, Adverse reactions | 310434 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | Preferred Pharmaceuticals Inc. | 11645bd6-7cfe-49b2-9292-2e4b0dbb84ae | 2025-06-04 | Warnings, Adverse reactions | 6CW7F3G59X |
| gabapentin | GABAPENTIN | Rising Pharma Holdings, Inc. | 969cccfc-e56a-49da-9d36-47c0c3fad7f8 | 2025-06-03 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | PAI Holdings, LLC dba PAI Pharma | 6d3fd1f9-c831-4262-af10-291838a53541 | 2025-05-31 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Rising Pharma Holdings, Inc. | 8215da86-d7af-4980-b6d6-4bd46f6bfeaf | 2025-05-30 | Warnings, Adverse reactions | 310433 6CW7F3G59X |
| Gabapentin | GABAPENTIN | ATLANTIC BIOLOGICALS CORP. | 5969f1a8-d6d5-4967-add5-4e2492354d7b | 2025-05-27 | Warnings, Adverse reactions | 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | Camber Pharmaceuticals, Inc. | 0ce53f62-1738-43f4-9a2e-c5dc42a91d09 | 2025-05-26 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | St. Mary's Medical Park Pharmacy | 7d3fc163-25f0-2c61-e053-2991aa0a76e9 | 2025-05-23 | Warnings, Adverse reactions | 310433 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Amneal Pharmaceuticals LLC | 772d9e7a-3811-455a-99e6-f2a3d0769b9b | 2025-05-13 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Aurobindo Pharma Limited | 1a619a14-0b63-4cba-80e7-474c9a1c90b9 | 2025-05-12 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Aurobindo Pharma Limited | 25cf6c40-a239-4dd0-9cad-28da84d285db | 2025-05-09 | Warnings, Adverse reactions | 310433 310434 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Proficient Rx LP | 3c8dca11-78ab-45c1-8bb2-89a41ea5dfa9 | 2025-05-01 | Warnings, Adverse reactions | 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | Exelan Pharmaceuticals, Inc. | 41d1ead3-046e-4abf-ae0a-cb126a1f5848 | 2025-05-01 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Actavis Pharma, Inc. | 5969871e-6c71-4c37-9d63-370718ccc80c | 2025-05-01 | Warnings, Adverse reactions | 6CW7F3G59X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.